Carson Thoreen

2011-2013 Biological Chemistry and Molecular Pharmacology Harvard University, Cambridge, MA, United States 
"Carson Thoreen"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Thoreen CC. (2021) Split-personality inhibitors. Nature Chemical Biology
Thoreen CC, Kang SA, Chang JW, et al. (2020) Correction: An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. The Journal of Biological Chemistry. 295: 2886
Thoreen CC. (2017) The molecular basis of mTORC1-regulated translation. Biochemical Society Transactions. 45: 213-221
Muranen T, Selfors LM, Hwang J, et al. (2016) ERK and p38 MAPK Activities Determine Sensitivity to PI3K/mTOR Inhibition via Regulation of MYC and YAP. Cancer Research
Son S, Stevens MM, Chao HX, et al. (2015) Cooperative nutrient accumulation sustains growth of mammalian cells. Scientific Reports. 5: 17401
Thoreen CC. (2013) Many roads from mTOR to eIF4F. Biochemical Society Transactions. 41: 913-6
Liu Q, Xu C, Kirubakaran S, et al. (2013) Characterization of Torin2, an ATP-competitive inhibitor of mTOR, ATM, and ATR. Cancer Research. 73: 2574-86
Thoreen CC, Chantranupong L, Keys HR, et al. (2012) A unifying model for mTORC1-mediated regulation of mRNA translation. Nature. 485: 109-13
Liu Q, Kirubakaran S, Hur W, et al. (2012) Kinome-wide selectivity profiling of ATP-competitive mammalian target of rapamycin (mTOR) inhibitors and characterization of their binding kinetics. The Journal of Biological Chemistry. 287: 9742-52
Liu Q, Kang SA, Thoreen CC, et al. (2012) Development of ATP-competitive mTOR inhibitors. Methods in Molecular Biology (Clifton, N.J.). 821: 447-60
See more...